| Literature DB >> 28049473 |
Duolong Zhu1,2, Yuxin Fu1, Fulu Liu1, Haijin Xu1, Per Erik Joakim Saris2, Mingqiang Qiao3,4.
Abstract
BACKGROUND: The implementation of novel chassis organisms to be used as microbial cell factories in industrial applications is an intensive research field. Lactococcus lactis, which is one of the most extensively studied model organisms, exhibits superior ability to be used as engineered host for fermentation of desirable products. However, few studies have reported about genome reduction of L. lactis as a clean background for functional genomic studies and a model chassis for desirable product fermentation.Entities:
Keywords: Chassis; Heterologous; Lactococcus lactis; LecC; Microbial cell factories; Red fluorescent protein
Mesh:
Substances:
Year: 2017 PMID: 28049473 PMCID: PMC5210298 DOI: 10.1186/s12934-016-0616-2
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Fig. 1Genetic organization and deletion of four large nonessential DNA regions in L. lactis 9 k. a Circular map of L. lactis 9 k chromosome showing the physical location of the deletions in the genome; b genetic organization of four large deletions; c distribution and annotations of ORFs found in the large deletions
Fig. 2Growth profiles and maximum specific growth rate (μmax) of strains. The μmax was determined during exponential growth. a Cultured in M17G media; b cultured in SA media. Data represent the mean of three independent experiments. Bars indicate standard deviations (*P < 0.05)
Fig. 3Biomass coefficient and yield of ATP on biomass. 1, L. lactis 9 k; 2, L. lactis 9 k-1; 3, L. lactis 9 k-2; 4, L. lactis 9 k-3; 5, L. lactis 9 k-4. a The biomass yield coefficient (Y X/S); b the yield of ATP on biomass (Y ATP/X). Data represent the mean of three independent experiments. Bars indicate standard deviations
Phenotype assay of metabolism
| Substrate consumption ratio compared to the wild strain (%) | ||||
|---|---|---|---|---|
| Substrate |
|
|
|
|
|
| 10.7 | 12.65 | 22.0 | 34.7 |
| Acetic acid | 15.3 | 18.6 | 18.6 | 19.5 |
|
| −3.6 | 18.7 | 67.0 | 56.4 |
| Maltose | −1.22 | 10.5 | 104.4 | 75.3 |
|
| 2.3 | 23.0 | −1.3 | 74.6 |
|
| −0.02 | 45.6 | 1.4 | 32.5 |
| α-methyl- | 2.4 | 1.4 | 41.5 | 28.6 |
| Maltotriose | 0.6 | 3.7 | 1.6 | 61.7 |
| α- | 1.2 | 1.3 | 2.1 | 7.9 |
| Stachyose | −2.2 | 4.2 | 5.1 | 60.1 |
| p-hydroxy-phenylacetic acid | −22.6 | −17.5 | −15.5 | −9.6 |
| N-acetyl-β- | −7.4 | −9.5 | −8.8 | −8.4 |
| α-Methyl- | −3.9 | −11.3 | −0.5 | −9.7 |
|
| −12.1 | 38.0 | −9.3 | −1.3 |
| α-ketoglutaric acid | −22.1 | −22.6 | 12.2 | −1.0 |
|
| 18.2 | −19.6 | −8.3 | −0.01 |
Fig. 4Relative quantity of lecC and rfp mRNA. 1, L. lactis 9 k-lecC; 2, L. lactis 9 k-1-lecC; 3, L. lactis 9 k-2-lecC; 4, L. lactis 9 k-3-lecC; 5, L. lactis 9 k-4-lecC; a, L. lactis 9 k-lecC; b, L. lactis 9 k-4-P5/lecC; c, L. lactis 9 k-4-P8/lecC. a Cultured in M17G media; b cultured in SA media; c cultured in SA or in M17G media without nisin; d cultured in SA or in M17G media with nisin to induce expression. Data represent the mean of three independent experiments. Bars indicate standard deviations (*P < 0.05)
Fig. 5Comparison of antibacterial activity of leucocin C expressed in different mutants. I induced expression, N non-induced expression. The commercial nisin were added to the cultures at a concentration of 10 IU/ml when needed
Fig. 6Comparison of antibacterial activity of leucocin C under control of the strong constitutive promoters P5 and P8 in the L. lactis 9 k-4. N non-induced expression
Fig. 7Comparison of fluorescence intensity of RFP and maximum specific rate of RFP formation (Kmax) in different mutants. Kmax was determined during exponential growth. The strain containing plasmid pNZ8048 was used as control. a Cultured in M17G media; b cultured in SA media. Data represent the mean of three independent experiments. Bars indicate standard deviations (*P < 0.05)
Bacterial strains and plasmids utilized in this study
| Item | Genotype or phenotype | Reference |
|---|---|---|
| Strains | ||
| | Cloning host; F-φ80 | [ |
| | Animal isolate (ATCC 1916), used as indicator strain | [ |
| | Constitutive strong promoters obtained from this strain | [ |
| | MG1363 | [ |
| | The first DNA region L1 (about 9.7 kb) deletion in | This work |
| | The L2 (about 22.5 kb) deletion in | This work |
| | The L3 (about 22.2 kb) deletion in | This work |
| | The L4 (about 21.6 kb) deletion in | This work |
| | Emr, | This work |
| | Emr, | This work |
| | Emr, | This work |
| | Emr, | This work |
| | Emr, | This work |
| | Emr, | This work |
| | Emr, | This work |
| | Cmr, | This work |
| | Cmr, | This work |
| | Cmr, | This work |
| | Cmr, | This work |
| | Cmr, | This work |
| Plasmids | ||
| pNZ5319 | Cmr, Emr, used as knock-out vector | [ |
| pNZ5319△L1 | Cmr, Emr, the first DNA region L1 knock-out vector | This work |
| NZ5319△L2 | Cmr, Emr, L2 knock-out vector | This work |
| pNZ5319△L3 | Cmr, Emr, L3 knock-out vector | This work |
| pNZ5319△L4 | Cmr, Emr, L4 knock-out vector | This work |
| pLEB124 | Emr, containing strong constitutive promoter P45 | [ |
| pEB690- | Nisinr, containing the P | [ |
| pLEB124- | Emr, pLEB124 derivative containing the P45+P | This work |
| pLEB124-P8/ | Emr, pLEB124 derivative containing the P8+P | This work |
| pLEB124-P5/ | Emr, pLEB124 derivative containing the P5+P | This work |
| pNZ8048 | Cmr | [ |
| pET-28a- | Kanr, containing | Aviva systems biology |
| pNZ8048- | Cmr, pNZ8048 derivative containing the | This work |